We conclude that the mineralocorticoid receptor antagonist spironolactone is an effective treatment of resistant hypertension because resistant hypertension is commonly a salt-retaining condition probably due to inappropriate aldosterone secretion. The gene discussed is NR3C2; the disease is hypertensive disorder.